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The ultimate stem cell, the oocyte, is frequently very large. For example, Drosophila and Xenopus oocytes are
105 times larger than normal somatic cells. Importantly, once the large oocytes are fertilized, the resulting
embryonic cells proliferate rapidly. Moreover, these divisions occur in the absence of cell growth and are not
governed by normal cell cycle controls. Observations suggest that mitogens and cell growth signals modulate
proliferation by upregulating G1-phase cyclins, which in turn promote cell division. Like embryonic cells, the
proliferation of cancer cells is largely independent of mitogens and growth factors. This occurs, in part, because
many proteins that are known to modulate G1-phase cyclin activity are frequently mutated in cancer cells. Inter-
estingly, we have found that both the expression and the activity of G1-phase cyclins is modulated by growth rate
and cell size in yeast. These and other data suggest that proliferative capacity correlates with cell size. Thus, a
major goal of our laboratory is to use yeast to investigate the relationship between proliferation rate, G1-phase
cyclins, growth rate, and cell size. The elucidation of this relationship will help clarify the role of cell size in
promoting proliferation in both normal and cancer cells.
Key words: cell size/Cln/G1-phase cyclins/growth rate
J Investig Dermatol Symp Proc 10:131 –141, 2005
The most obvious differences between different animals
are differences in cell size, but for some reason the zo-
ologists have paid singularly little attention to them.
J. B. S. Haldane, On Being the Right Size 1927
On Being the Right Size
Size is a fundamental and useful descriptive quality of all
organisms. Remarkably, organisms display an almost in-
comprehensible range of sizes. For example, the largest
organism, the Blue Whale, is over 19 billion times larger than
the smallest single cell plankton. Comparing the largest and
smallest multicellular organisms still reveals an amazing
spectrum of size. The smallest marine rotifer has less than
100 cells as compared with the nearly 100 quadrillion cells
of a Blue Whale. Given the amazing diversity of organism
size, it is striking that cells themselves are quite uniform in
size. Most animal cells are 10–20 mm in diameter and rarely
vary more than 2-fold outside of this size range (Tessier,
1939; Altman and Katz, 1961; Alberts et al, 1994; Conlon
and Raff, 1999). The relative constancy of cell size within
diverse organisms suggests that the mechanism of cell size
regulation is conserved. But despite these observations,
very little is known about the biological mechanisms that
control the size of cells or organisms.
The remarkable homogeneity of cell size observed in
populations of cells is achieved by coordination of cell
growth with division. This occurs because external stimuli,
such as nutrients, growth factors, and mitogens, stimulate
cell growth and division equivalently. Although often used
inter-changeably, it is important to stress that cell growth is
not synonymous with proliferation. Proliferation refers to in-
creases in cell numbers whereas growth refers to increases
in cell mass (discussed in Su and O’Farrell, 1998; Conlon
and Raff, 1999). Recently, the mechanisms that control the
regulation of cell size and act to coordinate cell growth with
proliferation have become an area of intense research (re-
viewed in Jorgensen and Tyers, 2004). Prior to the 1950s
research on cell size control was virtually non-existent. But
a Pub-Med literature search reveals that in the past 5 y there
has been an average of nearly 300 ‘‘cell size’’ manuscripts
per year as compared with an average of less than two per
year 40 y ago (Fig 1). This trend is likely to continue as more
and more important insights are being made into the ge-
netic, biochemical, and molecular mechanisms that ensure
cell size homeostasis (reviewed in Jorgensen and Tyers,
2004).
CDC Genes, Cdk, Cell Division
Several decades ago, Hartwell and coworkers achieved the
first insight into the mechanisms that coordinate cell growth
with proliferation (Hartwell et al, 1970, 1974; Hartwell, 1974;
Hartwell and Unger, 1977). By analyzing temperature-sen-
sitive mutants in the yeast Saccharomyces cerevisiae, they
found that the inactivation of some genes essential for pro-
liferation resulted in cells that arrested in specific phases of
the cell cycle. Because these mutants blocked progression
through the cell division cycle (cdc mutants), the genes en-
coding these mutants were called CDC genes (Hartwell
et al, 1970, 1974; Hartwell, 1974; Hartwell and Unger, 1977).
Analysis of the function of CDC genes has greatly elucidated
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the genetic and biochemical pathways that control cell
cycle progression (Hartwell et al, 1970, 1974; Hartwell,
1974; Hartwell et al, 1974; Hartwell and Unger, 1977).
Today, more than 50 CDC genes have been identified
(Murray and Hunt 1993). Most of these have been cloned
and nearly all have human homologues (Murray, 1993). Al-
though all cdc mutants result in specific cell cycle arrests,
the largest group consisting of 22 cdc mutants, arrest in G1
phase (Murray, 1993). Careful analysis of these mutants re-
vealed three fundamental details of the basic architecture of
the cell cycle.
First, it was discovered that the cell cycle is composed of
a series of inter-dependent steps that are initiated at the
transition point between G1 and S phase. Because of the
relationship between this transition and cell cycle progres-
sion, this point was named Start in yeast (Fig 2) (Hartwell
et al, 1970, 1974; Hartwell, 1974; Hartwell and Unger, 1977).
Subsequently, it was shown that Start is analogous to the
‘‘restriction point’’ in mammalian cells (Pardee, 1974; Zet-
terberg et al, 1995; Blagosklonny and Pardee, 2002) (Fig 2).
The archetype G1-phase CDC gene, CDC28, encodes a
cyclin-dependent kinase that is required for progression
past Start (reviewed in Reed et al, 1991; Reed, 1992; Nas-
myth, 1993; Cross, 1995; Futcher, 1996; Mendenhall and
Hodge, 1998). Importantly, CDC28 is highly conserved, and
a homologue, CDC2, has been identified in all higher
eukaryotes that have been examined (reviewed in Reed
et al, 1991; Reed, 1992; Nasmyth, 1993; Cross, 1995; Futc-
her, 1996; Mendenhall and Hodge, 1998). Like CDC28,
CDC2 is required for progression past the ‘‘restriction
point.’’
Second, it was found that progression past Start is de-
pendent upon cell growth and the attainment of a minimum
cell size (Hartwell and Unger, 1977; Johnston et al, 1977;
Carter and Jagadish, 1978; Johnston et al, 1979; Lorincz,
1979; Alberts et al, 1994) (Fig 2). A subset of G1-phase cdc
mutants blocks cell growth. In this manner, cells smaller
than the required minimum cell size arrest before Start
(Hartwell and Unger, 1977; Johnston et al, 1977, 1979;
Carter and Jagadish, 1978; Lorincz, 1979; Alberts et al,
1994). To date, little is known about the biochemical mech-
anisms responsible for linking cell growth and cell size to
proliferation.
Third, although it was shown that proliferation was de-
pendent upon cell growth, it was found that the converse is
not true. Most cdc mutants that arrest cells in G1 phase
continue to grow in mass at near normal rates (Hartwell and
Unger, 1977; Johnston et al, 1977, 1979; Carter and Jaga-
dish, 1978; Lorincz, 1979; Alberts et al, 1994). The manner in
which these cdc mutants prevent proliferation despite normal
cell growth is not well understood. Thus, a major aim of the
cell cycle field is the dissection of the molecular mechanism
that links cell growth with proliferation.
The genetic study of mutations that disrupt normal cell
size control in yeast has been extremely useful in elucidat-
ing the mechanisms that coordinate cell growth with pro-
liferation (reviewed in Jorgensen and Tyers, 2004). In the
1980s, yeast geneticists identified the first such cell size
mutant, whi1 (Sudbery et al, 1980). The whi1 mutant pro-
moted premature proliferation resulting in a phenotype of
abnormally small cells (Sudbery et al, 1980; Cross, 1988;
Nash et al, 1988). The cloning and analysis of this gene
revealed that it encoded a truncated and stabilized G1-
phase cyclin, Cln3, that upregulates the activity of the
Cdc28 (Sudbery et al, 1980; Cross, 1988; Nash et al, 1988).
Subsequently, it has been demonstrated that Clns are
rate-limiting for progression past Start (Dirick et al, 1995;
Schneider et al, 2004). Furthermore, over-expression of
G1-phase cyclins advances proliferation and dramatically
reduces cell size (Dirick et al, 1995; Schneider et al, 2004).
These observations have demonstrated that Cln–Cdc28 is
integral to cell size homeostasis.
Interestingly, much of what is known about cell size
homeostasis in higher eukaryotes has come from studying
cells where growth is not coordinated with proliferation
(Fig 3). Physiologically, this is a relatively rare event. For
instance, oocytes, neurons, and adipocytes can grow with-
out dividing leading to very large cells (Fig 3B) (discussed in
Conlon and Raff, 1999; Rudra and Warner, 2004). For ex-
ample, Drosophila and Xenopus oocytes are 105 times
larger than normal somatic cells. Once the large oocytes are
fertilized, the resulting embryonic cells proliferate rapidly.
Moreover, these divisions occur in the absence of cell
growth and are not governed by normal cell cycle controls
(Fig 3C). These observations have led to the theory that cell
Figure 1
The rapid pace of cell size research. A Pub-Med literature search
showed that in recent years, the number of publications on cell size
continues to increase at a very rapid pace.
Figure 2
Start is equivalent to the restriction point. In Saccharomyces
cerevisiae, cell division is clearly asymmetric resulting in a larger moth-
er cell (m) and a smaller daughter cell (d). Observations indicate that
smaller daughters require cell growth to a ‘‘critical cell size’’ in order to
progress past Start. Start is a point just prior to G1/S-phase boundary
equivalent to the restriction point in mammalian cells. Interestingly,
whereas by default mother cells are larger than the ‘‘critical cell size,’’
they still have a cell growth requirement for Start. It is not known if this
requirement is also governed by cell size.
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size may modulate the proliferative capacity of cells. Spe-
cifically, it has been suggested that commitment to prolif-
eration is dependent upon the attainment of a minimum
‘‘critical cell size’’ (discussed in Polymenis and Schmidt,
1999; Coelho and Leevers, 2000; Stocker and Hafen, 2000;
Potter and Xu, 2001; Rupes, 2002; Saucedo and Edgar,
2002; Conlon and Raff, 2003; Mitchison, 2003; Weitzman,
2003; Cooper, 2004; Jorgensen and Tyers, 2004; Schneider
et al, 2004). The ‘‘critical cell size’’ theory is supported by
the discovery that large cells can divide faster than they can
double their mass (Murray and Hunt 1993). It is this phe-
nomenon that allows extremely large oocytes to return to
the normal size of somatic cells (Fig 3C). Because it is pro-
posed that cells are unable to commit to cell division until a
minimum cell size is attained, this mechanism also prevents
normal somatic cells from getting continually smaller after
each division (Murray and Hunt 1993).
A number of observations in a variety of different organ-
isms support the ‘‘critical cell size’’ theory (discussed in
Polymenis and Schmidt, 1999; Coelho and Leevers, 2000;
Stocker and Hafen, 2000; Potter and Xu, 2001; Rupes,
2002; Saucedo and Edgar, 2002; Conlon and Raff, 2003;
Mitchison, 2003; Weitzman, 2003; Cooper, 2004; Jorgensen
and Tyers, 2004; Schneider et al, 2004). But because size is
a rather amorphous characteristic, it has proved very dif-
ficult to extend these observations from a correlative to
causative relationship. Moreover, despite the fact that G1-
phase Cdks are integral to both cell size homeostasis and
proliferation, the relationship between cell size, G1-phase
Cdk activity, and proliferative capacity is not well under-
stood. In addition, whereas cell growth is required for pro-
liferation, it is not known how cell size affects cell growth.
Finally, it is unclear how a cell might sense its size or how
cell size might trigger cell division. Thus, the two major
goals in this field are: (1) To determine if cell size has a
causative role in promoting cell division, and (2) To deter-
mine the molecular mechanism that links cell growth to
proliferative potential.
Like embryonic cells, the proliferation of cancer cells is
largely independent of mitogens and growth factors. This
occurs, in part, because the pathways known to modulate
G1-phase cyclin activity are mutated or disrupted in nearly
every cancer cell (Kastan and Bartek, 2004; Massague,
2004; Schneider and Kulesz-Martin, 2004). In fact, G1-
phase cyclin levels are elevated in a number of cancers
(Hunter and Pines, 1991; Steeg and Zhou, 1998; Geng et al,
2001; Moroy and Geisen, 2004; Schneider and Kulesz-Mar-
tin, 2004; Deshpande et al, 2005). This disrupts or elimi-
nates ‘‘restriction point’’ control leading to uncontrolled
proliferation, small cell size, and genomic instability (Stroh-
maier et al, 2001; Kramer et al, 2002; Spruck et al, 2002;
Tanaka and Diffley, 2002; Ekholm-Reed et al, 2004a, b;
Hubalek et al, 2004; Schneider and Kulesz-Martin, 2004).
Because of the central role of G1-phase Cdks in coordi-
nating cell growth with division, the elucidation of the ge-
netic, molecular, and biochemical details of these
mechanisms is likely to provide significant insight into the
role of these processes in promoting proliferation in both
normal and cancer cells. As the basic cell cycle machinery
is highly conserved, data obtained from model systems like
yeast will continue to be invaluable in dissecting the intri-
cacies and importance of appropriate cell cycle controls.
Here we show, in yeast cultures, that proliferative ca-
pacity correlates with cell size and cell growth rates. We
found that the time to Start is not constant for all cells but
has an inverse relationship to cell size. Large cells have a
higher proliferative potential. Supporting previous observa-
tions, we show that whereas G1-phase cyclin (Cln) abun-
dance is modulated by cell cycle position and cell size, it
correlates most closely with growth rate. For example, large
rapidly growing cells express considerably more Cln than
do small slowly growing cells. Investigation of new cell size
mutants revealed that a number of highly conserved signal
transduction pathways are involved in cell size home-
ostasis. Detailed analysis of specific cell size mutants indi-
cates that cell size homeostasis is achieved in part through
modulation of CLN transcription. But the discovery of novel
classes of cell size mutants indicates that the molecular
mechanism that coordinates cell growth with proliferation is
highly complex. Further analysis of genetic data obtained in
yeast should help to elucidate the complex relationship be-
tween cell size, G1-phase Cdk activity, and proliferative
potential and shed light on the role of these processes in
carcinogenesis.
Results
Cln abundance is modulated by cell cycle position and
cell size The yeast G1-phase cyclin, Cln3, modulates the
Figure 3
Cell growth and cell division. (A) In nearly all somatic cells, cell di-
vision is dependent upon cell growth. Homeostasis is maintained be-
cause on the average, cells double their mass before dividing. (B) In
contrast, in some cell types, cell growth and cell division can be un-
coupled. For example, neurons, oocytes, and adipocytes can grow
without dividing. (C) Cells that are unusually large (e.g., oocytes) can
proliferate in absence of cell growth. In this case, normal G1-phase cell
cycle controls are absent and cells divide rapidly. Homeostasis is
maintained because once cells become smaller than normal, cell
division again becomes dependent upon cell growth.
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transcription of two other G1-phase cyclins, Cln1 and Cln2
(reviewed in Nasmyth, 1993; Cross, 1995; Futcher, 1996;
Mendenhall and Hodge, 1998). Cln3 activates the transcrip-
tion of CLN1 and CLN2 in part by phosphorylating the yeast
orthologue, Whi5, of the mammalian RB tumor suppressor
gene (Costanzo et al, 2004; de Bruin et al, 2004; Schaefer
and Breeden, 2004). The ability of Cln3–Cdc28 to inactivate
Whi5 is a size-dependent process (Costanzo et al, 2004; de
Bruin et al, 2004; Schaefer and Breeden, 2004). But the
mechanisms that link cell size to Cln3 activity are not known
(reviewed in Nasmyth, 1993; Cross, 1995; Futcher, 1996;
Mendenhall and Hodge, 1998). Increased transcription of
CLN1 and CLN2 translates into higher Cln protein abun-
dance, which in turn stimulates progression past Start
(reviewed in Nasmyth, 1993; Cross, 1995; Futcher, 1996;
Mendenhall and Hodge, 1998). Recently, we showed that in
the absence of increased transcription, Cln1 protein abun-
dance is upregulated in a size-dependent manner (Schnei-
der et al, 2004). Initial experiments were done by expressing
CLN1 from a non-cell cycle regulated promoter, the GAL1
promoter, and measuring Cln1 protein abundance as a
function of cell size. Here, we have expanded upon this
observation by showing that Cln2 protein is similarly up-
regulated in a size-dependent manner in the absence of
changes in transcription.
To conduct these experiments, we used a construct
where the CLN2 gene was fused to the constitutive spADH
promoter. Under these circumstances, CLN2 transcription is
unaffected by cell cycle position or cell size. This construct
was transformed into a conditional Cln strain (e.g., GAL–
CLN1 cln2 cln3) (Schneider et al, 2004). In this strain, the
expression of CLN1 is dependent upon the presence of
galactose in the medium. In the absence of galactose, the
transformed spADH–CLN2 construct is the strain’s sole
CLN gene. This arrangement allowed us to investigate the
role of the transformed spADH–CLN2 construct in promot-
ing cell cycle progression independent of all endogenous
G1-phase cyclins. Cultures of this strain were grown to mid-
log phase in the absence of galactose, and centrifugal el-
utriation was used to obtain fractions of cells on the basis of
size. In this manner, eight fractions were obtained ranging in
size from 29 to 60 fL (Fig 4). Protein was isolated from each
fraction, and western analysis revealed that Cln2 abun-
dance increased dramatically as the cells got larger (Fig 4A).
Quantitation of the western data and normalization to the B-
tubulin loading controls revealed that Cln2 protein abun-
dance was more than 30-fold higher in the large 60 fL cells
as compared with the smaller 29 fL cells (Fig 4B). These
data confirm that both Cln1 and Cln2 protein abundance are
modulated by cell size.
Proliferation potential is cell size dependent Cell cycle
position correlates strongly with cell size. That is, G1-phase
cells tend to be smaller than S/G2/M-phase cells. In addi-
tion, progression past Start is believed to be size depend-
ent. But because the molecular details that link cell size to
cell cycle progression are not well understood, it remains
plausible that the relationship between cell size and prolif-
eration is entirely correlative and not causative. Here, we
have examined the relationship between cell size and pro-
liferative capacity using growth-arrested wild-type yeast
cells. The objective of these experiments was to answer
three questions. First, in minimally perturbed cultures that
are growth arrested in G1 phase, does the proliferative ca-
pacity of cells correlate closely with cell size or is the time to
Start constant regardless of cell size? Second, how does
cell size affect cell growth rates? Finally, given that Clns are
linked to proliferative capacity, does the abundance of Cln
protein correlate more closely with cell size or cell growth
rate?
To conduct these experiments, we grew a yeast culture
to saturation. After 4 d in culture, cells stopped growing and
proliferating. Flow cytometry analysis revealed that 499%
of the cells were in the G1 phase of the cell cycle. Subse-
quently, centrifugal elutriation was used to fractionate cells
on the basis of size. In this manner, six fractions were ob-
tained of cells that ranged from an average of 48 to 230 fL in
volume. Each fraction was resuspended in fresh medium
and returned to standard culture conditions. Cell cycle pro-
gression was monitored and the time to Start was deter-
mined as a measure of proliferative potential. Using this
minimally perturbed culture, it was found that even though
the cell division time of the asynchronous culture was con-
stant and stable, the time to Start for individual populations
of cells was extremely variable. Specifically, times to Start
ranged from 1.8 h for the largest cells to 9.5 h for the
smallest cells (Fig 5A). The near linear relationship between
cell size and proliferative capacity demonstrates that under
these conditions cell size correlates strongly with the prob-
ability of cell division.
Figure4
Cln protein levels are is modulated by cell size. A conditional Cln
yeast strain BS111 was transformed with a spADH–CLN2–HA con-
struct. In the presence of glucose, this construct is the only source of
Cln for this strain. In this case, in contrast to wild-type cells, CLN2
mRNA levels are constitutive and not cell size dependent. In contrast,
western analysis of elutriated fractions demonstrates that Cln2 protein
levels are size dependent. B-tubulin is used for a loading control. Lanes
N and P are negative (e.g., a strain with an untagged CLN2 gene) and
positive (e.g., CLN2–HA3 over-expressed from the GAL promoter)
controls. (B) Quantitation of the western data and normalization to the
B-tubulin loading controls revealed that Cln2 protein abundance was
more than 30-fold higher in the large 60 fL cells as compared with the
smaller 29 fL cells.
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In cycling cells, cell growth is required for progression
past Start. But the relationship between cell growth rate and
cell size is less clear. It is known that in asynchronous cul-
tures, rapidly proliferating cells are considerably larger than
slowly proliferating cells (Tyson et al, 1979; Schneider et al,
2004). Nevertheless, it is not known if cell growth is pro-
portional to cell size (discussed in Conlon and Raff, 2003,
2004; Cooper, 2004; Jorgensen and Tyers, 2004). In addi-
tion, it is not known if all cells have the same growth re-
quirement in order to progress past Start. To examine these
questions, we measured cell growth over time in each of the
six different size fractions that were collected. Analysis of
these data revealed that in the first five fractions of cells,
cell growth was size dependent (Fig 5B). That is, the
largest cells grew more rapidly than the smaller cells. For
instance, cells in the fifth fraction grew at an average of
nearly 14 fL per h (Fig 5B). In contrast, the smallest cells
grew at an average of about 1 fL per h (Fig 5B). Strikingly,
the overall growth requirement varied considerably. For ex-
ample, cells in the sixth fraction grew only 3 fL before Start
whereas cells in the fourth fraction grew 51 fL before Start
(Fig 5B,C). This clearly demonstrates that whereas the
probability that a given cell will divide correlates with cell
size, this size is not the same for all cells even under iden-
tical culture conditions. Rather, these data suggest that
proliferation potential is linked to both cell size and cell
growth rate.
Cln abundance is growth rate dependent We have pre-
viously shown that not only are Clns rate limiting for pro-
liferation but that a minimum threshold of Cln is required for
progression past Start (Schneider et al, 2004). Under phys-
iological conditions, this Cln threshold is attained in a size-
dependent manner (Schneider et al, 2004). This mechanism
helps link proliferation to cell size. In addition, we have
shown that Cln abundance and the Cln threshold level are
strongly modulated by growth rate and cell size (Schneider
et al, 2004). In this case, large rapidly growing cells express
and require more Cln in order to proliferate (Schneider et al,
2004). Because of this, we sought to determine the rela-
tionship between growth rate, cell size, and Cln abundance
in this experiment. Western analysis of cell fractions at Start
revealed that the abundance of Cln2 protein after normal-
ization to B-tubulin was size dependent in all but the largest
cell fractions (Fig 5C,D). Comparison of the relationship
between relative Cln abundance (Fig 5D) and relative
growth rates (Fig 5B) reveals that the two curves are near-
ly super-imposable. This strongly supports our previous
findings that Cln abundance and the apparent Cln require-
ment are strongly modulated by both cell size and growth
rate.
But the very large cells in the sixth fraction illustrate an
anomalous situation that runs counter to this generalization.
These cells, the largest of all the cell fractions, progress
past Start in the shortest period of time with the least
amount of Cln and the least amount of cell growth. Thus,
like embryonic cells, these yeast cells have the highest
proliferative potential and appear to be capable of dividing
in absence of normal growth and cell cycle controls. At this
time, the mechanisms responsible for these observations
are not known.
Figure 5
Proliferative capacity correlates with cell size. (A) A wild-type yeast
strain where the endogenous CLN1 gene is tagged with an HA epitope
was grown for 4 d at room temperature to saturation. Cell fractions of
different sizes were collected by centrifugal elutriation and then released
into fresh medium and incubated at room temperature. Time and size to
Start (50% budded) was determined for six different sized fractions. A
near linear relationship between cell size and proliferative capacity was
observed indicating that under these conditions cell size determines the
probability of cell division. (B) The rate of cell volume increase (fL per h)
was plotted for each fraction and found to be cell size dependent for
fractions 1–5. (C) The expression of Cln1–HA protein at Start in each
fraction was analyzed by the western blot. Initial size, cell size at Start,
and time to Start are given. B-tubulin is used for a loading control. Lanes
N and P are negative (e.g., a strain with an untagged CLN1 gene) and
positive (e.g., CLN1–HA3 over-expressed from the GAL promoter) con-
trols. (D) Quantitation of the western data and normalization to the B-
tubulin loading controls revealed that Cln1 protein abundance correlated
more closely to growth rate than to cell size.
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Cell size genetics and CLN transcription The analysis of
yeast cell size mutants has helped clarify the molecular
mechanisms involved in cell size homeostasis. But because
until recently very few cell size control genes were known,
the genetic pathways responsible for cell size homeostasis
have remained relatively obscure. Furthermore, elucidation
of the mechanism of cell size homeostasis has been recal-
citrant to genetic analysis primarily because of the difficulty
in cloning cell size control genes. One great advantage to
yeast is that nearly all of the 6200 ORFs have been sys-
tematically deleted in individual strains (Winzeler et al,
1999). Microscopic analysis of these deletions revealed that
it was feasible to perform a brute-force systematic genome-
wide genetic screen for cell size mutants (Fig 6A). Therefore,
to identify new size control genes, the effect of 5958 single
gene deletions (4792 homozygous and 1166 heterozygous
gene deletions) on cell size in yeast grown to saturation was
systematically determined using a Coulter Counter Chan-
nelyzer (Fig 6B). From these data, 49 genes were identified
that dramatically altered cell size without any obvious
growth defects (Zhang et al, 2002). Interestingly, these
genes clustered non-randomly into pathways. For example,
36 of these are involved in transcription, signal transduction,
or cell cycle control; 89% of these genes have putative hu-
man homologues (Zhang et al, 2002). Many of these genes
are components of Ccr4–Not transcriptional complexes
(Fig 7) or function in the PKC–MAP kinase pathway (Zhang
et al, 2002).
Prior to our screen, all known yeast cell size mutants
altered the expression or activity of G1-phase cyclins
(Sudbery et al, 1980; Cross, 1988; Nash et al, 1988, 2001;
Alberts et al, 1994; Radcliffe et al, 1997; Gari et al, 2001).
Based on this evidence, we examined the expression pat-
terns of CLN1 mRNA in a panel of the new cell size mutants.
Mutant cultures were grown to mid-log phase and centrif-
ugal elutriation was used to isolate synchronized small G1-
phase cells. Subsequently, these cells were resuspended in
fresh medium and cultured. Regular time points were taken,
and the CLN1 mRNA expression patterns were examined
by northern blotting (Fig 8A). Analysis of these data revealed
that in large cell size mutants (e.g., rpt2) CLN1 mRNA ex-
pression was delayed and peaked at larger than normal cell
sizes (Fig 8). In contrast, in small cell size mutants (e.g.,
sac1) CLN1 mRNA expression was advanced and peaked
at smaller than normal cell sizes (Fig 8). This general pattern
has held true for all cell size mutants examined to date.
But rigorous analysis of this mutant set has revealed that
mechanisms that control cell size homeostasis are likely to
be highly complex. All previous small cell size mutants,
promoted premature progression past Start and shortened
the G1 phase of the cell cycle (Sudbery et al, 1980; Cross,
1988; Nash et al, 1988, 2001; Alberts et al, 1994; Radcliffe
et al, 1997; Gari et al, 2001). In contrast, G1 phase was not
shortened in the majority of our new small cell size mutants.
In addition, we have found that many of these mutants
failed to correctly exit the cell cycle. Moreover, we have
identified two new classes of cell size mutants. Both of
these classes exhibit important growth defects. The first
class contains 181 mutants, all of which have mitochondrial
or respiratory defects. Interestingly, nearly all of these
Figure 6
Cell size mutants. (A) Photomicroscopy of a mixture of wild-type and
yeast mutants revealed that it was possible to differentiate large (U) and
small (W) cell mutants from wild-type cells (WT). Measurements indi-
cate that the largest mutants are  10-fold larger than the smallest.
Scale bar 5 mM. (B) Coulter counter analysis of 5958 single gene
deletion mutants. The number of deletion mutants was plotted as a
function of their mean size.
Figure7
The Ccr4–Not transcriptional complex. Analysis of cell size mutants
revealed that the Ccr4–Not transcriptional complex appears to be in-
volved in cell size regulation. Deletion of the genes for Hpr1, Paf1, Flr1,
Caf1, and Ccr4 (shaded gray) resulted in abnormally large cells. Inter-
estingly, all five of these gene products interact physically in Ccr4–Not
transcriptional complexes. Ccr4 is the core component of complexes
involved in transcription and poly (A) deadenylation. In addition, four
other gene products (shown in italics and underlined) are known to
effect cell size, cell cycle progression, or CLN expression.
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mutants are abnormally small. In addition, we identified 216
mutants that proliferated abnormally slowly. Of these, 58
were small cell size mutants, and 18 were large cell size
mutants. To date, we have no molecular explanation for
these results. But the fact that not all of the slowly prolif-
erating mutants were cell size mutants implies that the pro-
liferation defect alone is not responsible for the alteration in
cell size.
Discussion
Weighing in on the ‘‘critical cell size’’ theory The first
objective of the work presented here was to examine the
relationship between cell size and proliferative capacity.
Specifically, we sought to determine how closely the pro-
liferative capacity of cells correlates with cell size. The
‘‘critical cell size’’ theory postulates that the attainment of a
minimum cell size is required for commitment to cell divi-
sion. But opponents of this theory suggest that it is equally
possible that commitment to cell division is time dependent
rather than size dependent (Conlon and Raff, 2003; Weitz-
man, 2003). That is, if under a given condition, cells grew at
a constant rate, then the observed correlation between cell
size and proliferative capacity could be time dependent
(Conlon and Raff, 2003; Weitzman, 2003). In this case, it
would be expected that all cells would divide at a constant
rate regardless of cell size. Historically, a number of exper-
iments and observations suggest that this view is incorrect
(discussed in Cooper, 2004; Jorgensen and Tyers, 2004;
Grebien et al, 2005). For example, cell cycle and G1-phase
lengths are highly variable suggesting that a ‘‘simple timer’’
mechanism does not promote cell division (discussed in
Cooper, 2004; Jorgensen and Tyers, 2004; Grebien et al,
2005). In addition, artificially manipulating cell size dramat-
ically affects proliferative capacity (Cress and Gerner, 1977;
Johnston and Singer, 1983; Lord and Wheals, 1983; Singer
and Johnston, 1983; Moore, 1988). Hartmann and Prescott
demonstrated that cytoplasmic amputation prevents cell
division (Prescott, 1956a, b; Fantes et al, 1975). Remarka-
bly, continual repetition of this process prevented a single
amoeba from dividing for 6 mo whereas the control cell
divided 65 times (Prescott, 1956a, b; Fantes et al, 1975).
From this experiment, it was concluded that these cells
were continually monitoring their cell mass and not the
amount that they had grown nor the time that had elapsed
since their last division. Subsequently, researchers using
mouse cells showed that the probability that a given cell
would divide was proportional to its cell size (Shields et al,
1978). These studies have been greatly expanded upon in
both budding and fission yeast where numerous experi-
ments have revealed that cell size correlates closely with
the probability that a cell will divide (discussed in Cooper,
2004; Jorgensen and Tyers, 2004; Grebien et al, 2005). In
addition, recent experiments in mammalian cells support
the conclusion that cell size correlates closely with the pro-
liferative potential of cells (Dolznig et al, 2004; Rouzaire-
Dubois et al, 2004).
The data presented here using minimally perturbed and
growth arrested G1-phase yeast cultures also support the
‘‘critical cell size’’ theory. We found that the proliferative
potential of cells correlated closely to the size of cells. That
is the largest cells began to proliferate five times faster than
the smallest cells, and in general this trend continued until
the population reached a ‘‘normal’’ cell size. In this case, G1
phases and cell division times were not constant, but
instead they inversely correlated to cell size.
The second objective of this work was to examine how
cell size affects cell growth rates. Somatic cells require both
cell growth and high rates of protein synthesis to proliferate.
In contrast, embryonic cells can proliferate rapidly in the
absence of cell growth. Blocking the cell cycle with inhib-
itors generates abnormally large cells (Cress and Gerner,
1977; Johnston and Singer, 1983; Lord and Wheals, 1983;
Singer and Johnston, 1983; Moore, 1988). Upon release
from the cell cycle block, these cells proliferate rapidly
(Cress and Gerner, 1977; Johnston and Singer, 1983; Lord
Figure 8
CLN1 expression in cell size mutants. (A) Deletion of the gene for
Rpt2 results in abnormally large cells. Asynchronous cultures were el-
utriated and synchronized G1-phase cells were followed through a time
course. Northern analysis revealed that CLN1 mRNA peaked at 111 fL.
Asynchronous cultures (AS) are shown for reference. Blots were probed
with ACT1 to control for loading. (B) Deletion of the gene for Sac1
results in abnormally small cells. Asynchronous cultures were elutriated
and synchronized G1-phase cells were followed through a time course.
Northern analysis revealed that CLN1 mRNA peaked at 50 fL. AS
are shown for reference. Blots were probed with ACT1 to control for
loading. (C) Expression of relative levels CLN1 normalized to ACT1 in
sac1D and rpt2D mutants is plotted as a function of cell size. Under
these conditions, in wild-type cells CLN1 mRNA expression peaks
around 65 fL.
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and Wheals, 1983; Singer and Johnston, 1983; Moore,
1988). But the use of cell cycle inhibitors may create a non-
physiological scenario. Therefore, we wished to examine
the relationship between cell size, cell growth, and prolif-
eration under normal physiological conditions.
Again, using minimally perturbed and growth arrested
G1-phase yeast cultures, we measured the growth rate of
cells released to fresh medium. From these data, we found
that, in general, cell growth prior to Start was proportional to
cell size. That is, large cells grew more rapidly than small
cells. Interestingly, for the largest fraction of cells, this cor-
relation did not hold true. These cells had the shortest G1
phase and the smallest growth prior to Start. In addition, we
found that the growth requirement for Start was not the
same for all cells despite the fact that all of the cultures were
propagated under identical conditions. The largest cells
grew only 3 fL or 1% whereas the smallest cells grew 12 fL
or 25%. Interestingly, cell growth was highest in cells of
intermediate cell size where some cells grew as much as 51
fL or 40%. In summary, these data indicate that asynchro-
nous cultures are composed of discrete populations of
cells, each of which has unique cell cycle requirements. For
this reason, the relationship between cell size, cell growth,
and the proliferative potential of cells will probably be best
clarified by studying the kinetics of proliferation of single
cells rather than populations. The results presented here
suggest that there is apparently no absolute cell size, cell
growth or time requirement that ensures a given cell
will divide. These results demonstrate that the relationship
between cell growth, cell size, and proliferative poten-
tial is perhaps more complex than has been previously
suspected.
Cln substrates and Cln thresholds Clns are linked to
proliferative capacity, and we have shown that cells require
a minimal threshold level of Cln in order to proliferate
(Schneider et al, 2004). This threshold level of Cln varies with
growth rate (Schneider et al, 2004). Rapidly growing cells
require more Cln (Schneider et al, 2004). In addition, we
have shown that Cln abundance is modulated by cell size
(Schneider et al, 2004). Larger cells have a higher abun-
dance of Cln. Finally, we and others have shown that over-
expression of Cln leads to premature proliferation and dra-
matically reduces the size of cells (Tyers et al, 1993; Dirick
et al, 1995; Schneider et al, 2004). But to date, the molecular
explanation for these results is still largely unknown.
The final objective of this work was to determine if the
abundance of Cln protein correlates more closely with cell
size or cell growth rate. Here, we have shown that whereas
Cln protein abundance is modulated by cell size, the ab-
solute levels of Cln protein correlate more closely with
growth rate than with cell size. Because Clns are constitu-
tively unstable proteins, this type of mechanism may allow
cells to use Cln levels as a gauge of the synthetic capacity
of a cell (Schneider et al, 1998). It may be this mechanism
that links cell growth to proliferation.
Data indicate that rapidly growing cells express and re-
quire more Cln for cell division than do slowly growing cells.
To date, the molecular mechanisms responsible for these
observations are not known. One possibility is that the lev-
els of a G1-phase Cdk substrate may determine the Cln
requirement for proliferation. There are several known
substrates of Cln–Cdc28 kinase complexes. Most of these
are proteins involved in proper cell cycle regulation. Of
these, one of the most intriguing is Whi5. Deletion of WHI5
results in a small cell size phenotype (Jorgensen et al, 2002;
Zhang et al, 2002), and several recent elegant papers dem-
onstrate that Whi5 functions analogously to the pRB tumor
suppressor gene (Costanzo et al, 2004; de Bruin et al, 2004).
In this manner, it sequesters and represses the transcription
factors required for the expression of many G1/S-phase
genes (Costanzo et al, 2004; de Bruin et al, 2004). Thus,
Whi5 makes an excellent potential candidate for setting the
required Cln threshold for Start. The Cdk inhibitor Sic1 is
also a G1-phase Cdk substrate and several observations
suggest that is a putative candidate for setting the Cln
threshold (Schneider et al, 1996; Tyers, 1996; Nash et al,
2001).
Supersize me: The implications of being big During
gametogenesis, cells destined to become gametes arrest
cell cycle progression, but cells continue to grow. Because
of this, oocytes can achieve sizes that are 105 times
larger than normal somatic cells. Importantly, once the large
oocytes are fertilized, the resulting embryonic cells prolif-
erate rapidly. In addition, these cell divisions occur in the
absence of cell growth. We have recently shown that cell
size also affects the developmental options available to
yeast where entry into meiosis is dependent upon the at-
tainment of a minimum cell size (Day et al, 2004). Here, we
have shown that ‘‘supersized’’ yeast cells can be selected
from wild-type cultures grown under physiological condi-
tions. This result illustrates that despite the fact that the
average cell size in a population is remarkably stable, cells
grown under physiological conditions display a wide range
( 5-fold) of cell sizes. These extra large cells display many
of the characteristics of fertilized oocytes. Like embryonic
cells, they proliferate rapidly in the absence of cell growth
and normal cell cycle controls. This rapid proliferation in the
absence of growth leads to a reduction in average cell size
over time. In addition, we have shown that these ‘‘super-
sized’’ yeast cells express and appear to require very low
levels of G1-phase cyclins. In an attempt to elucidate the
molecular mechanisms responsible for these observations,
we have identified and analyzed a panel of new cell size
mutants. Data from this analysis has revealed that many of
the pathways involved in cell size homeostasis are strongly
conserved from yeast to man (Jorgensen et al, 2002; Zhang
et al, 2002). Moreover, most of these pathways modulate
the expression and activity of G1-phase Cdks. Components
of these pathways are known to be mutated in nearly every
cancer cell suggesting that these signal transduction cas-
cades are vital to the maintenance of normal cellular repro-
duction (reviewed in Kastan and Bartek, 2004; Massague,
2004). The high degree of conservation of these basic cell
cycle pathways suggests that genetic data obtained from
model organisms like yeast will continue to be invaluable in
dissecting the mechanism whereby cells couple cell growth
with division to achieve balanced, stable, and developmen-
tally appropriate proliferation.
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Materials and Methods
Strains and media Strains used in this work are derived from
W303. Yeast cultures were grown in YEP-based media (20.0 g
Difco Bacto peptone and 10.0 g Difco Bacto yeast extract were
dissolved in 900 mL of water and autoclaved) or YNB-based media
(6.7 g Difco-Bacto yeast nitrogen base lacking amino acids and
ammonium sulfate was added to 900 mL of water and autoclaved).
Required amino acids were supplemented at 50 mg per liter except
for tryptophan (80 mg per liter), adenine sulfate (32 mg per liter),
and p-aminobenzoic acid (5 mg per liter). After autoclaving, sterile
filter carbon sources were added to a final concentration of 2%
(glucose or galactose).
Preparation of RNA and northern analysis Yeast cultures were
grown to a mid-log phase (1–3  107 cells per mL). Cultures were
chilled rapidly by adding an equal volume of ice to media. The cells
were pelleted by centrifugation at 41C and washed in ice-cold wa-
ter. Cell pellets were frozen at 801C. Pellets were resuspended in
250 mL of LETS buffer (100 mM LiCl, 10 mM EDTA, 10 mM Tris-HCl,
pH 7.4, and 0.2% SDS). Subsequently, 300 mL of LETS-equilibrat-
ed phenol and an equal volume of 450 nm acid-washed glass
beads were added. The cell suspensions were vortexed at max-
imum speed for 30 s, and then an additional 200 mL of LETS was
added. The cell suspensions were vortexed briefly and then cen-
trifuged for 5 min at 16,000  g. The upper aqueous phase was
removed and extracted twice with phenol/chloroform. RNA was
precipitated by adding 1/10 volume of 5 M LiCl and 2.5 volumes of
ice cold ethanol, then incubated 1–12 h at 201C. After precip-
itation, RNA was recovered by centrifuging 15 min at 14,000 r.p.m.
followed by a wash with 70%–80% ethanol. RNA pellets were air-
dried at room temperature and resuspended in 50–100 mL DEPC-
treated water. Size separation of RNA was performed using 1.0%
denaturing agarose gels containing 6.6% formaldehyde and 1 
MOPS. Typically, 10 mg of RNA was lyophilized in a Savant speed
vac and resuspended in 5 mL of DEPC-treated water. Subsequent-
ly, 17.5 mL of RNA loading buffer was added (12.5 mM MOPS, pH
7.1, 2.5 mM NaOAC, 0.25 mM EDTA, 3.1% formaldehyde, 25%
formamide, 2% glycerol dye, 4 mg per mL bromphenol blue, 4 mg
per mL xylene blue, and 50 mg per mL ethidium bromide), heated at
651C for 15 min and loaded onto a gel that was pre-run at 90 V for
20 min. Gels were run for 30 min at 45V and then at 90 V for 3–5 h.
After electrophoresis, gels were soaked in DEPC-treated water
with gentle shaking for 45 min and then transferred to Nytran-
Plus nylon membranes (Schleicher and Schuell Florham Park, New
Jersey) as recommended by the manufacturer. After transfer, nu-
cleic acids were cross-linked to membranes using UV light (UV
Stratalinker 1800, Stratagene La Jolla, California) as recommended
by the manufacturer. Hybridization of membranes was performed
as previously described using Church hybridization buffer (7% w/v
SDS, 0.1% w/v BSA (fraction V (Sigma St. Louis, Missouri)), 0.1
mM EDTA, and 0.25 M Na2HPO4 pH 7.2) (Tyers et al, 1993). Filters
were pre-incubated in hybridization buffer for 30 min at 651C. Ra-
dioactive probes were made using a32P-ATP and a random prime
labeling kit from Roche Applied Science, Indianapolis, Indiana.
Probes were purified on G-50 sephadex spin columns, denatured
by boiling for 5 min, and then added to pre-hybridization buffer and
incubated 12–16 h at 651C. Subsequently, blots were washed once
with 2  SSC for 5 min, twice with 2  SSCþ 0.1% SDS (pre-
heated to 651C) at 651C for 15 min, twice with, and finally in
2  SSC for 15 min. Filters were wrapped in plastic wrap and ex-
posed to Kodak XAR film or a Molecular Dynamics (Rochester,
New York) phosphoimager screen for further analysis.
Protein extraction and Western analysis Yeast extracts for
Western analysis were prepared as previously described (Tyers
et al, 1993). Briefly, yeast pellets were lysed in a mini-beadbeater
cell disrupter (Biospecs Bartlesvilte, Oklahoma) using 0.5 mm di-
ameter acid-washed baked zirconia beads in the presence of
buffer 3 (0.1% NP40, 250 mM NaCI, 50 mM NaF, 5 mM EDTA, and
50 mM Tris-HCl pH 7.5) and proteinase inhibitors (1 mM PMSF, l mg
per mL leupeptin, 1 mg per mL pepstatin, 0.6 mM dimethylami-
nopurine, 10 mg per mL soybean trypsin inhibitor, and 1 mg per mL
TPCK). Cell debris was pelleted by centrifuging at 16,000  g. for
15 min. Protein concentrations were determined with the Bio-Rad
(Hercules, California) dye-binding assay according to the manu-
facturer’s specifications. For western analysis, 50 mg of protein
lysates were mixed with an equal volume of 2  protein sample
and samples were boiled for 2 min. Samples were loaded onto
small 10% SDS-PAGE gels and run at 75–100 V. Protein gels were
transferred to nitrocellulose using a semi-dry transfer apparatus
(Millipore Billerica, Massachusetts) and probed consecutively with
primary anti-HA antibody 12CA5 (diluted 1:5000) and secondary
HRP-conjugated Sheep anti-mouse (1:20,000 Amersham Piscat-
away, New Jersey). Proteins were visualized using the Amersham
ECL system or the Pierce Supersignal system according to the
manufacturer’s specifications.
Quantiﬁcation of cell size, percent of budded cells, and cell
cycle distributions Cell cycle synchronizations were performed
using centrifugal elutriation as previously described (Day et al,
2004). Cell cycle synchrony was confirmed using microscopic
analysis and flow cytometry. The percent of budded cells was de-
termined by coding samples and then counting the number of cells
with visible buds in a minimum of 200 cells. The percent of budded
cells was verified in at least two independent experiments. For flow
cytometry, yeast cells were harvested, washed, sonicated, and
fixed overnight in 70% ethanol at 41C. Cells were resuspended in
50 mM sodium citrate, washed in the same buffer, sonicated,
treated with RNAse A (final concentration 0.25 mg per mL) for 1 h
at 501C, and treated with Proteinase K (final concentration 1 mg
per mL) for an additional hour at 501C. Before analysis the yeast
cells were stained with propidium iodide at a final concentration of
16 mg per mL. Flow cytometry was performed on yeast cells
stained with propidium iodide with an Epics XL (Beckman-Coulter
Fullerton, California) flow cytometer. Analysis of the cell size dis-
tribution of yeast strains was done using cultures in mid-log phase.
Samples of the cultures were resuspended in 10 mL of Isoton
buffer, briefly sonicated, and immediately analyzed using a Coulter
Counter Channelyzer Model Z2 (Beckman-Coulter) (100 micron
aperture).
We thank M. Tyers and B. Futcher for useful reagents and J. Hutson
and S. Williams for helpful discussions and comments. This research
was supported by grants from the American Heart Association, The CH
Foundation, the Wendy Will Cancer Fund, the Houston Endowment
Incorporation, the South Plains Foundation, and Texas Tech University
Health Sciences Center to B. L. S.
DOI: 10.1111/j.1087-0024.2005.200414.x
Manuscript received December 15, 2004; accepted for publication
June 22, 2005
Address correspondence to: Brandt L. Schneider, Department of Cell
Biology and Biochemistry, Texas Tech University Health Sciences
Center, 3601 4th St. Rm 5C119, Lubbock, Texas 79430, USA. Email:
brandt.schneider@ttuhsc.edu
References
Alberts B, Bray D, Lewis J, Raff M, Watson JD: Molecular Biology of the Cell.
New York: Garland, 1994
Altman PL, Katz DD: Blood and Other Body Fluids. Washington: Federation of
American Societies for Experimental Biology, 1961
Blagosklonny MV, Pardee AB: The restriction point of the cell cycle. Cell Cycle
1:103–110, 2002
Carter BL, Jagadish MN: The relationship between cell size and cell division in the
yeast Saccharomyces cerevisiae. Exp Cell Res 112:15–24, 1978
SIZE AND PROLIFERATION 13910 : 2 NOVEMBER 2005
Coelho CM, Leevers SJ: Do growth and cell division rates determine cell size in
multicellular organisms? J Cell Sci 113 (Part 17):2927–2934, 2000
Conlon I, Raff M: Size control in animal development. Cell 96:235–244, 1999
Conlon I, Raff M: Differences in the way a mammalian cell and yeast cells
coordinate cell growth and cell-cycle progression. J Biol 2:1–10, 2003
Conlon I, Raff M: Control and maintenance of mammalian cell size: Response.
BMC Cell Biol 5:36–37, 2004
Cooper S: Control and maintenance of mammalian cell size. BMC Cell Biol 5:
5–35, 2004
Costanzo M, Nishikawa JL, Tang X, et al: CDK activity antagonizes Whi5, an
inhibitor of G1/S transcription in yeast. Cell 117:899–913, 2004
Cress AE, Gerner EW: Hydroxyurea treatment affects the G1 phase in next gen-
eration CHO cells. Exp Cell Res 110:347–353, 1977
Cross FR: DAF1, a mutant gene affecting size control, pheromone arrest, and cell
cycle kinetics of Saccharomyces cerevisiae. Mol Cell Biol 8:4675–4684,
1988
Cross FR: Starting the cell cycle: What’s the point? Curr Opin Cell Biol 7:790–797,
1995
Day A, Markwardt J, Delaguila R, Zhang J, Purnapatre K, Honigberg SM, Schn-
eider BL: Cell size and Cln–Cdc28 complexes mediate entry into meiosis
by modulating cell growth. Cell Cycle 3:38–44, 2004
Day A, Schneider C, Schneider BL: Yeast cell synchronization. Methods Mol Biol
241:55–76, 2004
de Bruin RA, McDonald WH, Kalashnikova TI, Yates J III, Wittenberg C: Cln3
activates G1-specific transcription via phosphorylation of the SBF bound
repressor Whi5. Cell 117:887–898, 2004
Deshpande A, Sicinski P, Hinds PW: Cyclins and cdks in development and
cancer: A perspective. Oncogene 24:2909–2915, 2005
Dirick L, Bohm T, Nasmyth K: Roles and regulation of Cln–Cdc28 kinases at the
start of the cell cycle of Saccharomyces cerevisiae. EMBO J 14:4803–
4813, 1995
Dolznig H, Grebien F, Sauer T, Beug H, Mullner EW: Evidence for a size-sensing
mechanism in animal cells. Nat Cell Biol 6:899–905, 2004
Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed SI:
Deregulation of cyclin E in human cells interferes with prereplication
complex assembly. J Cell Biol 165:789–800, 2004a
Ekholm-Reed S, Spruck CH, Sangfelt O, et al: Mutation of hCDC4 leads to
cell cycle deregulation of cyclin E in cancer. Cancer Res 64:795–800,
2004b
Fantes PA, Grant WD, Pritchard RH, Sudbery PE, Wheals AE: The regulation of
cell size and the control of mitosis. J Theor Biol 50:213–244, 1975
Futcher B: Cyclins and the wiring of the yeast cell cycle. Yeast 12:1635–1646,
1996
Gari E, Volpe T, Wang H, Gallego C, Futcher B, Aldea M: Whi3 binds the mRNA of
the G1 cyclin CLN3 to modulate cell fate in budding yeast. Genes Dev
15:2803–2808, 2001
Geng Y, Yu Q, Whoriskey W, et al: Expression of cyclins E1 and E2 during mouse
development and in neoplasia. Proc Natl Acad Sci USA 98:13138–13143,
2001
Grebien F, Dolznig H, Beug H, Mullner EW: Cell size control: New evidence for a
general mechanism. Cell Cycle 4:418–421, 2005
Hartwell LH: Saccharomyces cerevisiae cell cycle. Bacteriol Rev 38:164–198,
1974
Hartwell LH, Culotti J, Pringle JR, Reid BJ: Genetic control of the cell division
cycle in yeast. Science 183:46–51, 1974
Hartwell LH, Culotti J, Reid B: Genetic control of the cell-division cycle in yeast. I.
Detection of mutants. Proc Natl Acad Sci USA 66:352–359, 1970
Hartwell LH, Unger MW: Unequal division in Saccharomyces cerevisiae and its
implications for the control of cell division. J Cell Biol 75:422–435, 1977
Hubalek MM, Widschwendter A, Erdel M, et al: Cyclin E dysregulation and chro-
mosomal instability in endometrial cancer. Oncogene 23:4187–4192,
2004
Hunter T, Pines J: Cyclins and cancer. Cell 66:1071–1074, 1991
Johnston GC, Ehrhardt CW, Lorincz A, Carter BL: Regulation of cell size in the
yeast Saccharomyces cerevisiae. J Bacteriol 137:1–5, 1979
Johnston GC, Pringle JR, Hartwell LH: Coordination of growth with cell division in
the yeast Saccharomyces cerevisiae. Exp Cell Res 105:79–98, 1977
Johnston GC, Singer RA: Growth and the cell cycle of the yeast Saccharomyces
cerevisiae. I. Slowing S phase or nuclear division decreases the G1 cell
cycle period. Exp Cell Res 149:1–13, 1983
Jorgensen P, Nishikawa JL, Breitkreutz BJ, Tyers M: Systematic identification
of pathways that couple cell growth and division in yeast. Science
297:395–400, 2002
Jorgensen P, Tyers M: How cells coordinate growth and division. Curr Biol
14:R1014–R1027, 2004
Kastan MB, Bartek J: Cell-cycle checkpoints and cancer. Nature 432:316–323,
2004
Kramer A, Neben K, Ho AD: Centrosome replication, genomic instability and
cancer. Leukemia 16:767–775, 2002
Lord PG, Wheals AE: Rate of cell cycle initiation of yeast cells when cell size is not
a rate-determining factor. J Cell Sci 59:183–201, 1983
Lorincz A, Coulter Bi-A: Control of cell size at bud initiation in Saccharomyces
cerevisiae. J Gen Micro 113:287–295, 1979
Massague J: G1 cell-cycle control and cancer. Nature 432:298–306, 2004
Mendenhall MD, Hodge AE: Regulation of Cdc28 cyclin-dependent protein kin-
ase activity during the cell cycle of the yeast Saccharomyces cerevisiae.
Microbiol Mol Biol Rev 62:1191–1243, 1998
Mitchison JM: Growth during the cell cycle. Int Rev Cytol 226:165–258, 2003
Moore SA: Kinetic evidence for a critical rate of protein synthesis in the Sac-
charomyces cerevisiae yeast cell cycle [published erratum appears
in J Biol Chem 1988 Dec 5;263(34):18582]. J Biol Chem 263:9674–9681,
1988
Moroy T, Geisen C: Cyclin E. Int J Biochem Cell Biol 36:1424–1439, 2004
Murray A, Hunt: The Cell Cycle. Oxford: University Press, 1993
Nash P, Tang X, Orlicky S, et al: Multisite phosphorylation of a CDK inhibitor
sets a threshold for the onset of DNA replication. Nature 414:514–521,
2001
Nash R, Tokiwa G, Anand S, Erickson K, Futcher AB: The WHI1þ gene of Sac-
charomyces cerevisiae tethers cell division to cell size and is a cyclin
homolog. EMBO J 7:4335–4346, 1988
Nash RS, Volpe T, Futcher B: Isolation and characterization of WHI3, a size-
control gene of Saccharomyces cerevisiae. Genetics 157:1469–1480,
2001
Nasmyth K: Control of the yeast cell cycle by the Cdc28 protein kinase. Curr Opin
Cell Biol 5:166–179, 1993
Pardee AB: A restriction point for control of normal animal cell proliferation. Proc
Natl Acad Sci USA 71:1286–1290, 1974
Polymenis M, Schmidt EV: Coordination of cell growth with cell division. Curr
Opin Genet Dev 9:76–80, 1999
Potter CJ, Xu T: Mechanisms of size control. Curr Opin Genet Dev 11:279–286,
2001
Prescott DM: Relation between cell growth and cell division. II. The effect of cell
size on cell growth rate and generation time in Amoeba proteus. Exp Cell
Res 11:86–94, 1956a
Prescott DM: Relation between cell growth and cell division. III. Changes in nu-
clear volume and growth rate and prevention of cell division in Amoeba
proteus resulting from cytoplasmic amputations. Exp Cell Res 11:94–98,
1956b
Radcliffe P, Trevethick J, Tyers M, Sudbery P: Deregulation of CLN1 and CLN2 in
the Saccharomyces cerevisiae whi2 mutant. Yeast 13:707–715, 1997
Reed SI: The role of p34 kinases in the G1 to S-phase transition. Annu Rev Cell
Biol 8:529–561, 1992
Reed SI, Wittenberg C, Lew DJ, Dulic V, Henze M: G1 control in yeast and animal
cells. Cold Spring Harb Symp Quant Biol 56:61–67, 1991
Rouzaire-Dubois B, Malo M, Milandri JB, Dubois JM: Cell size-proliferation re-
lationship in rat glioma cells. Glia 45:249–257, 2004
Rudra D, Warner JR: What better measure than ribosome synthesis? Genes Dev
18:2431–2436, 2004
Rupes I: Checking cell size in yeast. Trends Genet 18:479–485, 2002
Saucedo LJ, Edgar BA: Why size matters: Altering cell size. Curr Opin Genet Dev
12:565–571, 2002
Schaefer JB, Breeden LL: RB from a bud’s eye view. Cell 117:849–850, 2004
Schneider BL, Kulesz-Martin M: Destructive cycles: The role of genomic insta-
bility and adaptation in carcinogenesis. Carcinogenesis 25:2033–2044,
2004
Schneider BL, Patton EE, Lanker S, Mendenhall MD, Wittenberg C, Futcher B,
Tyers M: Yeast G1 cyclins are unstable in G1 phase. Nature 395:86–89,
1998
Schneider BL, Yang QH, Futcher AB: Linkage of replication to start by the Cdk
inhibitor Sic1. Science 272:560–562, 1996
Schneider BL, Zhang J, Markwardt J, Tokiwa G, Volpe T, Honey S, Futcher B:
Growth rate and cell size modulate the synthesis of, and requirement for,
G1-phase cyclins at start. Mol Cell Biol 24:10802–10813, 2004
Shields R, Brooks RF, Riddle PN, Capellaro DF, Delia D: Cell size, cell cycle and
transition probability in mouse fibroblasts. Cell 15:469–474, 1978
Singer RA, Johnston GC: Growth and the cell cycle of the yeast Saccharomyces
cerevisiae. II. Relief of cell-cycle constraints allows accelerated cell di-
visions. Exp Cell Res 149:15–26, 1983
Spruck CH, Strohmaier H, Sangfelt O, et al: hCDC4 gene mutations in endome-
trial cancer. Cancer Res 62:4535–4539, 2002
Steeg PS, Zhou Q: Cyclins and breast cancer. Breast Cancer Res Treat 52:17–28,
1998
Stocker H, Hafen E: Genetic control of cell size. Curr Opin Genet Dev 10:
529–535, 2000
140 ZHANG ET AL JID SYMPOSIUM PROCEEDINGS
Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI: Human F-box
protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast
cancer cell line. Nature 413:316–322, 2001
Su TT, O’Farrell PH: Size control: Cell proliferation does not equal growth. Curr
Biol 8:R687–R689, 1998
Sudbery PE, Goodey AR, Carter BL: Genes which control cell proliferation in the
yeast Saccharomyces cerevisiae. Nature 288:401–404, 1980
Tanaka S, Diffley JF: Deregulated G1-cyclin expression induces genomic in-
stability by preventing efficient pre-RC formation. Genes Dev 16:
2639–2649, 2002
Tessier G: Biometrie de la cellule. Tabulae Biol 19:1–64, 1939
Tyers M: The cyclin-dependent kinase inhibitor p40SIC1 imposes the requirement
for Cln G1 cyclin function at Start. Proc Natl Acad Sci USA 93:7772–7776,
1996
Tyers M, Tokiwa G, Futcher B: Comparison of the Saccharomyces cerevisiae G1
cyclins: Cln3 may be an upstream activator of Cln1, Cln2 and other
cyclins. EMBO J 12:1955–1968, 1993
Tyson CB, Lord PG, Wheals AE: Dependency of size of Saccharomyces
cerevisiae cells on growth rate. J Bacteriol 138:92–98, 1979
Weitzman JB: Growing without a size checkpoint. J Biol 3:2–5, 2003
Winzeler EA, Shoemaker DD, Astromoff A, et al: Functional characterization of
the S. cerevisiae genome by gene deletion and parallel analysis. Science
285:901–906, 1999
Zetterberg A, Larsson O, Wiman KG: What is the restriction point? Curr Opin Cell
Biol 7:835–842, 1995
Zhang J, Schneider C, Ottmers L, Rodriguez R, Day A, Markwardt J, Schneider
BL: Genomic scale mutant hunt identifies cell size homeostasis genes in
S. cerevisiae. Curr Biol 12:1992–2001, 2002
SIZE AND PROLIFERATION 14110 : 2 NOVEMBER 2005
